A number of additional studies have also shown that eIF3d is involved in tumorigenesis via translational regulation of oncogene expression (18, 21, 22, 23, 24), suggesting that it may serve potentially as a novel biomarker and cancer therapeutic target. The gene discussed is EIF3D; the disease is cancer.